HQ_MED_Drugs_(PH NO.:49132) RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR 150 MCG/GM GEL - 15 GM.
STORES/SOUTH CENTRAL RLY · Pharmaceuticals · open
Key facts
- Published: 24 Jul 2026
- Closing date: 10 Aug 2026
- Status: open
Description
Tender for the supply of Recombinant Human Epidermal Growth Factor Gel (150 mcg/gm, 15 gm) to South Central Railway, with a closing date of 10 August 2026, 10:30 AM. The tender is limited, for indigenous goods, with a single bid system, and includes specific eligibility and compliance conditions.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Limited - Indigenous
- Evaluation: Itemwise/Consigneewise
- Make in India (MII): No
- MSE preference: No
Line items (1)
- Recombinant Human Epidermal Growth Factor Gel — Qty: 4 Numbers
5 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals